Principal Investigator:
Iman Hajirasouliha, Associate Professor of Systems and Computational Biomedicine
Background & Unmet Need
- Current IVF success heavily depends on accurate embryo assessment, requiring multiple complex tasks including ploidy prediction, quality scoring, and developmental monitoring
- Traditional diagnostic tools are costly, lack standardization, and often rely on invasive procedures like PGT-A testing
- Current AI models are constrained by insufficient training data diversity, reliance on manual input, and limited accessibility for clinical adoption
- Available AI platforms show reduced accuracy when analyzing specific developmental stages and lack standardization across different clinical settings
- High costs and varying regulations around genetic testing create barriers to access for many patients
- Unmet Need: Efficient non-invasive, and standardized approach for comprehensive embryo assessment
Technology Overview
- The Technology: FEMI is a foundation model trained on ~18 million time-lapse embryo images for comprehensive, non-invasive assessment of embryo viability and development
- Self-supervised learning approach enables comprehensive feature extraction without manual annotation requirements
- A single unified platform handles multiple critical assessment tasks through task-specific fine-tuning
- PoC Data: Achieves >0.75 AUROC for ploidy prediction using single images, improving to >0.80 AUROC with video sequences and >0.85 AUROC when including maternal age data
- Demonstrates >90% F1 score in embryo tracking across 96-112 hours post-insemination
- Predicts developmental timing with mean absolute errors under 6 hours across datasets
Technology Applications
- Clinical decision support tool for IVF clinics enabling standardized embryo selection
- Potential applications in broader reproductive medicine research and developmental biology for studying embryo morphology and development patterns
Technology Advantages
- State-of-the-art performance across multiple embryo assessment tasks
- Standardized, objective analysis with generalization across multiple clinical settings and datasets, enabling consistent embryo assessment protocols
- Provides cost-effective implementation through seamless integration with existing time-lapse imaging equipment in IVF clinics

Intellectual Property
Patents
- US Patent 12,014,833: "System and method for selecting artificially fertilized embryos"
- IL Patent 280645: "System and method for selecting artificially fertilized embryos"
- US Application: "Predicting embryo ploidy status using time-lapse images"
- Provisional Application Filed
Cornell Reference
- 11620
Contact Information
For additional information please contact
Donna Rounds
Associate Director, Business Development and Licensing
Phone: (646) 780-8775
Email: djr296@cornell.edu
